{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:04:14Z","timestamp":1773108254412,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"publisher","award":["2018YFF01012100"],"award-info":[{"award-number":["2018YFF01012100"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing evidence has revealed the close link between mitochondrial dynamic dysfunction and cancer. MIEF2 (mitochondrial elongation factor 2) is mitochondrial outer membrane protein that functions in the regulation of mitochondrial fission. However, the expression, clinical significance and biological functions of MIEF2 are still largely unclear in human cancers, especially in ovarian cancer (OC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression and clinical significance of MIEF2 were determined by qRT-PCR, western blot and immunohistochemistry analyses in tissues and cell lines of OC. The biological functions of MIEF2 in OC were determined by in vitro and in vivo cell growth and metastasis assays. Furthermore, the effect of MIEF2 on metabolic reprogramming of OC was determined by metabolomics and glucose metabolism analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MIEF2 expression was significantly increased in OC mainly due to the down-regulation of miR-424-5p, which predicts poor survival for patients with OC. Knockdown of MIEF2 significantly suppressed OC cell growth and metastasis both in vitro and in vivo by inhibiting G1-S cell transition, epithelial-to-mesenchymal transition (EMT) and inducing cell apoptosis, while forced expression of MIEF2 had the opposite effects. Mechanistically, mitochondrial fragmentation-suppressed cristae formation and thus glucose metabolism switch from oxidative phosphorylation to glycolysis was found to be involved in the promotion of growth and metastasis by MIEF2 in OC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MIEF2 plays a critical role in the progression of OC and may serve as a valuable prognostic biomarker and therapeutic target in the treatment of this malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-020-01802-9","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T08:04:06Z","timestamp":1607933046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer"],"prefix":"10.1186","volume":"39","author":[{"given":"Shuhua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-0829","authenticated-orcid":false,"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"10177","key":"1802_CR1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer [J]. Lancet. 2019;393(10177):1240\u201353.","journal-title":"Lancet"},{"issue":"4","key":"1802_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine [J]. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin"},{"key":"1802_CR3","doi-asserted-by":"crossref","unstructured":"Krzystyniak J, Ceppi L, Dizon DS, et al. Epithelial ovarian cancer: The molecular genetics of epithelial ovarian cancer. Ann Oncol, 2016,27 Suppl 1 i4-i10.","DOI":"10.1093\/annonc\/mdw083"},{"issue":"2","key":"1802_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1871520616666161031143301","volume":"17","author":"L Schwartz","year":"2017","unstructured":"Schwartz L, Supuran CT, Alfarouk KO. The Warburg effect and the hallmarks of cancer [J]. Anti Cancer Agents Med Chem. 2017;17(2):164\u201370.","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"1","key":"1802_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","volume":"54","author":"Y Kato","year":"2018","unstructured":"Kato Y, Maeda T, Suzuki A, et al. Cancer metabolism: new insights into classic characteristics [J]. The Japanese dental science review. 2018;54(1):8\u201321.","journal-title":"The Japanese dental science review"},{"key":"1802_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: Progress and prospects. Molecular cancer. 2013;12:152.","journal-title":"Molecular cancer"},{"issue":"10","key":"1802_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Tumour acidosis: from the passenger to the driver's seat [J]. Nat Rev Cancer. 2017;17(10):577\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1802_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, et al. Mitochondrial metabolism and cancer [J]. Cell Res. 2018;28(3):265\u201380.","journal-title":"Cell Res"},{"issue":"4","key":"1802_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-018-9769-2","volume":"37","author":"PM Herst","year":"2018","unstructured":"Herst PM, Grasso C, Berridge MV. Metabolic reprogramming of mitochondrial respiration in metastatic cancer [J]. Cancer Metastasis Rev. 2018;37(4):643\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"2 Pt A","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu J, Tan M, Cai Q. The warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356(2 Pt A):156\u201364.","journal-title":"Cancer Lett"},{"issue":"1","key":"1802_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbcan.2017.01.002","volume":"1868","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Cancer cell metabolism and mitochondria: nutrient plasticity for tca cycle fueling [J]. Biochim Biophys Acta Rev Cancer. 2017;1868(1):7\u201315.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"12","key":"1802_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm3013","volume":"11","author":"B Westermann","year":"2010","unstructured":"Westermann B. Mitochondrial fusion and fission in cell life and death [J]. Nat Rev Mol Cell Biol. 2010;11(12):872\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1802_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1042\/BST20160129","volume":"44","author":"H Lee","year":"2016","unstructured":"Lee H, Yoon Y. Mitochondrial fission and fusion [J]. Biochem Soc Trans. 2016;44(6):1725\u201335.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1802_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/EBC20170104","volume":"62","author":"L Tilokani","year":"2018","unstructured":"Tilokani L, Nagashima S, Paupe V, et al. Mitochondrial dynamics: overview of molecular mechanisms [J]. Essays Biochem. 2018;62(3):341\u201360.","journal-title":"Essays Biochem"},{"issue":"11","key":"1802_CR15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00018-016-2451-3","volume":"74","author":"AP Trotta","year":"2017","unstructured":"Trotta AP, Chipuk JE. Mitochondrial dynamics as regulators of cancer biology [J]. Cell Mol Life Sci. 2017;74(11):1999\u20132017.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1802_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","volume":"12","author":"Q Huang","year":"2016","unstructured":"Huang Q, Zhan L, Cao H, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ros-modulated coordinated regulation of the nfkb and tp53 pathways [J]. Autophagy. 2016;12(6):999\u20131014.","journal-title":"Autophagy"},{"issue":"34","key":"1802_CR17","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1038\/onc.2017.98","volume":"36","author":"J Li","year":"2017","unstructured":"Li J, Huang Q, Long X, et al. Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress [J]. Oncogene. 2017;36(34):4901\u201312.","journal-title":"Oncogene"},{"issue":"11","key":"1802_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41419-018-1083-y","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang J, Lyu Z, et al. Positive feedback loop between mitochondrial fission and notch signaling promotes survivin-mediated survival of tnbc cells [J]. Cell Death Dis. 2018;9(11):1050.","journal-title":"Cell Death Dis"},{"issue":"40","key":"1802_CR19","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao J, Zhang J, Yu M, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells [J]. Oncogene. 2013;32(40):4814\u201324.","journal-title":"Oncogene"},{"issue":"13","key":"1802_CR20","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1038\/s41388-020-1176-9","volume":"39","author":"M Qi","year":"2020","unstructured":"Qi M, Dai D, Liu J, et al. Aim2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics [J]. Oncogene. 2020;39(13):2707\u201323.","journal-title":"Oncogene"},{"issue":"5","key":"1802_CR21","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1096\/fj.11-196543","volume":"26","author":"J Rehman","year":"2012","unstructured":"Rehman J, Zhang HJ, Toth PT, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer [J]. FASEB J. 2012;26(5):2175\u201386.","journal-title":"FASEB J"},{"key":"1802_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mito.2013.10.004","volume":"16","author":"D Tailor","year":"2014","unstructured":"Tailor D, Hahm ER, Kale RK, et al. Sodium butyrate induces drp1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells. Mitochondrion. 2014;16:55\u201364.","journal-title":"Mitochondrion"},{"issue":"13","key":"1802_CR23","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","volume":"77","author":"RJ Reiter","year":"2020","unstructured":"Reiter RJ, Sharma R, Ma Q, et al. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: A mechanistic hypothesis [J]. Cellular and molecular life sciences : CMLS. 2020;77(13):2527\u201342.","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ebiom.2018.07.026","volume":"34","author":"C Kingnate","year":"2018","unstructured":"Kingnate C, Charoenkwan K, Kumfu S, et al. Possible roles of mitochondrial dynamics and the effects of pharmacological interventions in chemoresistant ovarian cancer. EBioMedicine. 2018;34:256\u201366.","journal-title":"EBioMedicine"},{"issue":"18","key":"1802_CR25","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.yexcr.2013.07.010","volume":"319","author":"T Liu","year":"2013","unstructured":"Liu T, Yu R, Jin SB, et al. The mitochondrial elongation factors mief1 and mief2 exert partially distinct functions in mitochondrial dynamics [J]. Exp Cell Res. 2013;319(18):2893\u2013904.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1802_CR26","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","volume":"8","author":"A Nagy","year":"2018","unstructured":"Nagy A, Lanczky A, Menyhart O, et al. Validation of mirna prognostic power in hepatocellular carcinoma using expression data of independent datasets [J]. Sci Rep. 2018;8(1):9227.","journal-title":"Sci Rep"},{"issue":"2","key":"1802_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J]. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1802_CR28","doi-asserted-by":"publisher","first-page":"e17429","DOI":"10.1371\/journal.pone.0017429","volume":"6","author":"EA Shirdel","year":"2011","unstructured":"Shirdel EA, Xie W, Mak TW, et al. Navigating the micronome--using multiple microrna prediction databases to identify signalling pathway-associated micrornas [J]. PLoS One. 2011;6(2):e17429.","journal-title":"PLoS One"},{"issue":"1","key":"1802_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O'Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls t cell fate through metabolic programming [J]. Cell. 2016;166(1):63\u201376.","journal-title":"Cell"},{"key":"1802_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annual review of cell and developmental biology. 2011;27:441\u201364.","journal-title":"Annual review of cell and developmental biology"},{"issue":"4","key":"1802_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, et al. The cell biology of mitochondrial membrane dynamics [J]. Nat Rev Mol Cell Biol. 2020;21(4):204\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1802_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcancer.2017.06.006","volume":"47","author":"HK Kim","year":"2017","unstructured":"Kim HK, Noh YH, Nilius B, et al. Current and upcoming mitochondrial targets for cancer therapy. Semin Cancer Biol. 2017;47:154\u201367.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1802_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00018-018-2963-0","volume":"76","author":"LG de Almeida Chuffa","year":"2019","unstructured":"de Almeida Chuffa LG, Seiva FRF, Cucielo MS, et al. Mitochondrial functions and melatonin: A tour of the reproductive cancers [J]. Cellular and molecular life sciences : CMLS. 2019;76(5):837\u201363.","journal-title":"Cellular and molecular life sciences : CMLS"},{"issue":"48","key":"1802_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018228","volume":"98","author":"L Yu","year":"2019","unstructured":"Yu L, Xiao Z, Tu H, et al. The expression and prognostic significance of drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry [J]. Medicine (Baltimore). 2019;98(48):e18228.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1802_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/abbs\/gmx137","volume":"50","author":"YY Kim","year":"2018","unstructured":"Kim YY, Yun SH, Yun J. Downregulation of drp1, a fission regulator, is associated with human lung and colon cancers [J]. Acta Biochim Biophys Sin Shanghai. 2018;50(2):209\u201315.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"2","key":"1802_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/15548627.2016.1256520","volume":"13","author":"J Hu","year":"2017","unstructured":"Hu J, Meng Y, Zhang Z, et al. March5 rna promotes autophagy, migration, and invasion of ovarian cancer cells [J]. Autophagy. 2017;13(2):333\u201344.","journal-title":"Autophagy"},{"issue":"9","key":"1802_CR37","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1111\/jcmm.13749","volume":"22","author":"Q Tang","year":"2018","unstructured":"Tang Q, Liu W, Zhang Q, et al. Dynamin-related protein 1-mediated mitochondrial fission contributes to ir-783-induced apoptosis in human breast cancer cells [J]. J Cell Mol Med. 2018;22(9):4474\u201385.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1802_CR38","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-018-0987-x","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li H, Chang H, et al. Mtp18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma [J]. Cell Death Dis. 2018;9(10):956.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1802_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41416-019-0658-4","volume":"122","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li TE, Chen M, et al. Mfn1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming [J]. Br J Cancer. 2020;122(2):209\u201320.","journal-title":"Br J Cancer"},{"key":"1802_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biopha.2018.03.018","volume":"102","author":"J Wang","year":"2018","unstructured":"Wang J, Wang S, Zhou J, et al. Mir-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer. Biomed Pharmacother. 2018;102:147\u201352.","journal-title":"Biomed Pharmacother"},{"key":"1802_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.028","volume":"224","author":"H Du","year":"2019","unstructured":"Du H, Xu Q, Xiao S, et al. Microrna-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting trim29. Life Sci. 2019;224:1\u201311.","journal-title":"Life Sci"},{"issue":"2","key":"1802_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bjc.2015.195","volume":"113","author":"R Matsushita","year":"2015","unstructured":"Matsushita R, Seki N, Chiyomaru T, et al. Tumour-suppressive microrna-144-5p directly targets ccne1\/2 as potential prognostic markers in bladder cancer [J]. Br J Cancer. 2015;113(2):282\u20139.","journal-title":"Br J Cancer"},{"key":"1802_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2017.01.006","volume":"171","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, An Q, Guo RX, et al. Mir424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting kdm5b via the notch signaling pathway. Life Sci. 2017;171:9\u201315.","journal-title":"Life Sci"},{"issue":"3","key":"1802_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/15384101.2017.1407894","volume":"17","author":"J Liu","year":"2018","unstructured":"Liu J, Gu Z, Tang Y, et al. Tumour-suppressive microrna-424-5p directly targets ccne1 as potential prognostic markers in epithelial ovarian cancer [J]. Cell Cycle. 2018;17(3):309\u201318.","journal-title":"Cell Cycle"},{"issue":"10","key":"1802_CR45","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00018-015-1840-3","volume":"72","author":"T Mikawa","year":"2015","unstructured":"Mikawa T, ME LL, Takaori-Kondo A, et al. Dysregulated glycolysis as an oncogenic event [J]. Cell Mol Life Sci. 2015;72(10):1881\u201392.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1802_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","volume":"1807","author":"C Jose","year":"2011","unstructured":"Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma? [J]. Biochim Biophys Acta. 2011;1807(6):552\u201361.","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-020-01802-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:55:09Z","timestamp":1697338509000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01802-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01802-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-97858\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Fourth Military Medical University. Informed consent was obtained from all individual participants included in the study.Animal studies in nude mice were approved by the Institutional Animal Experiment Committee of Xijing hospital and carried out in accordance with the UK Animals (Scientific Procedures) Act, 1986.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No financial and non-financial competing interests exist in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}